Luxembourg is a dynamic multicultural country in the heart of Europe with a strong research and development culture supported by important financial and organizational resources. It offers state-of-the-art facilities and an excellent training environment for early-stage researchers, in life sciences and systems biomedicine.
Within Luxembourg, high level innovative biomedical research is carried out at the Luxembourg Institute of Health (LIH) as well as at the Luxembourg Centre for Systems Biomedicine and the Department of Life Sciences and Medicine of the University of Luxembourg.
NEXTIMMUNE2, standing for “Next Generation ImmunoScience: Advanced Concepts for Deciphering Acute and Chronic Inflammation 2”, is the second edition of our competitive PhD training program, supported by the doctoral research funding scheme PRIDE of the Luxembourg National Research Fund (FNR). It aims to integrate classical immunology and big-data analysis science in a structured doctoral training environment that is focused on two innovate research areas, immunometabolism and systems immunology.
What we offer:
19 PhD STUDENT positions are available with up to 4 years fixed-term contracts, full-time.
Earliest start date will be beginning of 2023, after a comprehensive and competitive selection process starting in September 2022. Further positions can be filled over the next 24 months.
The research-intensive program aims to respond to the unmet needs of training competent immunologists in an interdisciplinary environment by tackling next-generation immunology challenges from wet-lab procedures to big data.
The program covers analysis of “omics” and clinical data, as well as basic and translational biomedical knowledge.
The program includes transferable skills training, support in career development, scientific lectures by international speakers and annual PhD retreats.
PhD candidates will conduct their research projects either at the LIH’s Department of Infection and Immunity (Esch-sur-Alzette), at the LIH’s Department of Cancer Research (Strassen), at the Laboratoire National de Santé (Dudelange) or at the Luxembourg Centre for Systems Biomedicine and at the Department of Life Sciences and Medicine of the University of Luxembourg (Campus Belval, Esch-sur-Alzette). All PhD candidates will be enrolled at the University of Luxembourg.
The program will allow the candidates to obtain a PhD degree in Biology with a specialization in either:
- Systems immunology
- Fundamental immunology
- Chronic inflammation and autoimmunity
- Molecular and cellular allergology
- Epigenetics applied to immunology
More information on NextImmune2 and the available positions/projects can be found here: https://www.lih.lu/en/nextimmune2/
What we expect from you…
We are seeking excellent and highly motivated candidates holding a Master’s degree (MSc or equivalent) in a field related to the topics of the PhD program. Very good English language skills are required as English is the working language.
How to apply…
Applications including the following mandatory documents:
- cover letter stating up to 3 project preferences (please provide the project numbers in title of the cover letter)
- a full curriculum vitae with at least 2 references (contact details only)
- the relevant diplomas showing marks (MSc, MD or equivalent)
We ensure a full consideration for applications received by 1 September 2022.
More specific information on Nextimmune2 can be obtained from the program coordinator, Prof Dirk Brenner, Deputy Director (Research & Strategy) of LIH’s Department of Infection and Immunity: email@example.com